The Phia Group Blog

By: David Ostrowsky Many Americans have long viewed melatonin as a harmless supplement that’s readily accessible on the shelf at the local grocers or CVS. Certainly, millions consider melatonin to be an effective sleep aid with minimal side effects and…

By: Bryan M. Dunton, Esq. It may feel like everyone is suddenly talking about prescription drugs and pharmacy benefit managers (PBMs) this year, and that’s because they are. PBM reform has shifted from obscure policy debates to a regulatory groundswell…

By: Kate MacDonald If you want to connect with family, friends, or long-lost classmates, you have your pick of social media platforms. From Facebook, to Instagram, to Threads, and everything in between, there are ways to not only maintain connections,…

By: David Ostrowsky It’s starting earlier this year. And it may even be more complicated. Generally speaking, flu season begins in earnest around Christmas and accelerates into the new year. But this year, the early days of the holiday season…

By: David Ostrowsky The Center for Drug Evaluation and Research (CDER), charged with regulating most prescription drugs and over-the-counter medicines, is quite possibly the most high-powered regulatory division of the U.S. Food and Drug Administration (FDA). Indeed, tens of millions…

By: David Ostrowsky For the better part of the 2020s, Pharmacy Benefit Managers, more colloquially known as PBMs, have been heavily scrutinized and even maligned for their business practices. Some critics have alleged that PBMs are responsible for engaging in…